TOG Review (RCOG Journal)
MRCOG Part 2
Sexual and Reproductive Health
Contraceptive methods and issues around the menopause
Key Statistics
- 1 in 5 — Pregnancies ≥40y unplanned (NATSAL)
- 6× — ↑VTE risk with CHC
- 50/55y — Stop non-hormonal/all contraception age
Don't-miss facts
-
No contraceptive method is contraindicated on age alone up to age 50y
-
Stop rules: ≥50y non-hormonal – 1yr amenorrhoea; <50y – 2yr; on POP/implant/IUS ≥50y – 1yr after 2×FSH >30 IU/l (≥6wk apart); or stop at 55y
-
Sequential HRT inhibits ovulation in only 40% – NOT contraceptive; only 52 mg IUS gives licensed endometrial protection with HRT
-
CHC VTE risk up to 6× baseline (2/10,000/yr); continuous use safer than stop–start (risk rises again after ≥1 month break)
-
Nexplanon® = most effective reversible method, 3 years, no BMD effect, effective to 149 kg
-
Depo Provera®: ~5% bone loss in first 2 years; FSRH – consider stopping at 50y
-
EC: LNG to 72h, UPA to 120h, copper IUD most effective (always offer); avoid progestogen contraception for 5 days post- UPA
-
Sterilisation failure: female 1:200, vasectomy 1:2000; counsel on LARC alternatives first
Failure rates (typical use, %/year)
Implant 0.05 IUS 0.2 IUD 0.8 Injectable 6.0 CHC 9.0 POP 9.0
Abbreviation Key
- WHO — World Health Organization
- UKMEC — UK Medical Eligibility Criteria
- FSH — follicle stimulating hormone
- HMB — heavy menstrual bleeding
- FSRH — Faculty of Sexual and Reproductive Healthcare
- STI — sexually transmitted infection
- HRT — hormone replacement therapy
- PID — pelvic inflammatory disease
- IUC — intrauterine contraception
- ALO — actinomyces-like organism
- IUS — intrauterine system
- EC — emergency contraception
- IUD — intrauterine device
- LNG — levonorgestrel
- IUB — intrauterine ball
- UPA — ulipristal acetate
- LARC — long-acting reversible contraception
- UPSI — unprotected sexual intercourse
- CHC — combined hormonal contraception
- PRM — progesterone receptor modulator
- POP — progestogen-only pill
- NATSAL — National Survey of Sexual Attitudes and Lifestyles
- VTE — venous thromboembolism
- NICE — National Institute for Health and Care Excellence
- OR — odds ratio
Source: Bakour SH, Hatti A, Whalen S. Contraceptive methods and issues around the menopause: an evidence update. The Obstetrician & Gynaecologist 2017;19:289–97. doi:10.1111/tog.12416
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).